You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 338.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.6 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 5.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -5.75 | -1,067.50p | -0.6 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -3.55 | -237.50p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -4.83 | -117.50p | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -2.72 | -32.50p | -0.5 | 0.0 | n/a | n/a | 0.0% |
| Physiomics and ValiRx enter new collaboration deal Sharecast News | 15 Feb |
|---|---|
| ValiRx adds four new patents to portfolio in 2020 Sharecast News | 19 Jan |
| ValiRx looks to build on portfolio of drug candidates Sharecast News | 06 Jul |
| Total Voting Rights | 01-Mar-21 07:01 |
|---|---|
| Block listing Interim Review | 25-Feb-21 07:00 |
| Director/PDMR Shareholding | 18-Feb-21 15:39 |
| Extension of Collaboration Agreement | 15-Feb-21 07:00 |
| Director Disclosure | 19-Jan-21 11:36 |